Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry
Jitendra PS. Sawhney(Sir Ganga Ram Hospital), Pekka Raatikainen, Sylvia Haas(TUM Klinikum), A. John Camm(St George's, University of London), Karen S. Pieper(Clinical Research Institute), Samuel Z. Goldhaber(Brigham and Women's Hospital), Alex C. Spyropoulos(Lenox Hill Hospital), V. Vanajakshamma(Sri Venkateswara Institute of Medical Sciences), Hany Ragy, Shinya Goto(Tokai University), Keith A.A. Fox(University of Edinburgh), LG Mantovani(IRCCS Istituto Auxologico Italiano), Petr Jánský(Charles University), Frank Cools, Ramón Corbalán(Pontificia Universidad Católica de Chile), Rajashekhar Durgaprasad(Sri Venkateswara Institute of Medical Sciences), Jagan Allu(Thrombosis Research Institute), Jean‐Pierre Bassand(Observatoire des Sciences de l’Univers Terre Homme Environnement Temps Astronomie), David Fitzmaurice(University of Warwick), Gloria Kayani(Thrombosis Research Institute), Ramdhan Meena(S.R. Kalla Memorial Gastro and General Hospital), Marianne Brodmann(Medical University of Graz), Stuart J. Connolly(Population Health Research Institute), Bernard J. Gersh(Clinical Research Institute), G Vijayaraghavan(Kerala Institute of Medical Sciences), V A Kothiwale(KLE Society Hospital), John W. Eikelboom(Population Health Research Institute), Jørn Dalsgaard Nielsen, Frank Misselwitz, Praveen Jadhav(Sujata Birla Hospital and Medical Research Center), Werner Hacke(Heidelberg University), Alexander G.G. Turpie(McMaster University), Ajay K. Kakkar(Thrombosis Research Institute), Vikas Bisne(Apex Heart Institute), Kamaldeep Chawla(Sterling Hospitals), Dayi Hu, Manoj Chopda, Martin van Eickels(Sanofi (Mexico)), Héctor Luciardi, Antônio Carlos Pereira Barretto(Universidade de São Paulo), Freek W.A. Verheugt(OLVG), Harry Gibbs(Monash University)
Cited by 21
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.4k
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
|European Heart Journal|2014|3.1k